Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Gewählte Publikation:

SHR Neuro Krebs Kardio Lipid Stoffw Microb

Gary, T; Pichler, M; Belaj, K; Hafner, F; Gerger, A; Froehlich, H; Eller, P; Rief, P; Hackl, G; Pilger, E; Brodmann, M.
Platelet-to-lymphocyte ratio: a novel marker for critical limb ischemia in peripheral arterial occlusive disease patients.
PLoS One. 2013; 8(7):e67688-e67688 Doi: 10.1371/journal.pone.0067688 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG


Führende Autor*innen der Med Uni Graz
Gary Thomas
Co-Autor*innen der Med Uni Graz
Belaj Klara
Brodmann Marianne
Eller Philipp
Fröhlich Harald
Gerger Armin
Hackl Gerald
Hafner Franz
Pichler Martin
Pilger Ernst
Rief Peter

Dimensions Citations:

Plum Analytics:

Scite (citation analytics):

Platelet-to-Lymphocyte Ratio (PLR) is an easily applicable blood test. An elevated PLR has been associated with poor prognosis in patients with different oncologic disorder. As platelets play a key role in atherosclerosis and atherothrombosis, we investigated PLR and its association with critical limb ischemia (CLI) and other vascular endpoints in peripheral arterial occlusive disease (PAOD) patients. We evaluated 2121 PAOD patients treated at our institution from 2005 to 2010. PLR was calculated and the cohort was categorized into tertiles according to the PLR. An optimal cut-off value for the continuous PLR was calculated by applying a receiver operating curve analysis to discriminate between CLI and non-CLI. In our cohort occurrence of CLI significantly increased with an increase in PLR. As an optimal cut-off value, a PLR of 150 was identified. Two groups were categorized, one containing 1228 patients (PLR≤150) and a second group with 893 patients (PLR>150). CLI was more frequent in PLR>150 patients (410(45.9%)) compared to PLR≤150 patients (270(22.0%)) (p<0.001), as was prior myocardial infarction (51(5.7%) vs. 42(3.5%), p = 0.02). Regarding inflammatory parameters, C-reactive protein (median 7.0 mg/l (3.0-24.25) vs. median 5.0 mg/l (2.0-10.0)) and fibrinogen (median 457 mg/dl (359.0-583.0) vs. 372 mg/dl (317.25-455.75)) also significantly differed in the two patient groups (both p<0.001). Finally, a PLR>150 was associated with an OR of 1.9 (95%CI 1.7-2.1) for CLI even after adjustment for other well-established vascular risk factors. An increased PLR is significantly associated with patients at high risk for CLI and other cardiovascular endpoints. The PLR is a broadly available and cheap marker, which could be used to highlight patients at high risk for vascular endpoints.
Find related publications in this database (using NLM MeSH Indexing)
Aged -
Biomarkers - analysis
Blood Platelets - metabolism
C-Reactive Protein - metabolism
Extremities - blood supply
Female -
Fibrinogen - metabolism
Humans -
Ischemia - blood
Lymphocyte Count -
Lymphocytes - metabolism
Male -
Middle Aged -
Peripheral Arterial Disease - blood
Platelet Count -
Risk Assessment -
Risk Factors -

© Med Uni Graz Impressum